Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 6, 2000, Pages 588-591

  Casal, M ^a,c   Ruiz, P ^a   Herreras, A ^b  

^a Mycobacteria Reference Laboratory   (Argentina)

^b Hoechst Marion Roussel   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

In vitro susceptibility; Ofloxacin; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; FEMALE; HUMAN; IN VITRO STUDY; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPAIN; TUBERCULOSIS;

ADULT; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; SPAIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0034097899     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sudre P, Ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1982; 70: 149-159.
2. Sepkowitz K A. Tuberculosis in the AIDS era. Clin Microbiol Rev 1985; 8: 180-199.
3. Iseman M. Treatment of multi-resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
4. Centers for Disease Control. Outbreak of multidrug resistant tuberculosis. Morb Mort Weekly Rep 1990; 39: 369-372.
5. Gillespie S H, Kennedy N. Fluoroquinolones: a new treatment for tuberculosis? Int J Tuberc Lung Dis 1998; 2: 265-271.
6. Centers for Disease Control. Treating tuberculosis. A clinical guide. Atlanta, GA: CDC, 1994.
7. Chung-Hua Chen, Jen Fu Shih, Lindholm-Levy P J, Heifets L B. Minimal inhibitory concentration of rifabutin, ciprofloxacin and ofloxacin against M. tuberculosis. Am Rev Respir Dis 1989; 140: 987-989.
8. Rastogi N, Ross B C, Dwyer B, et al. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 1992; 11: 901-907.
9. Vestal A L. Procedures for isolation and identification of Mycobacteria. Atlanta, GA: Centers for Disease Control, 1975.
10. Roberts G D, Goodman N L, Heifets L, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear positive specimens. J Clin Microbiol 1997; 18: 689-696.
11. Heifets L B. Drug susceptibility tests in the management of chemotherapy of tuberculosis. In: Heifets L B, ed. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton, Florida: CRC Press, Inc, 1991: pp 90-115.
12. Casal M, Gutierrez J, González J, Ruiz P. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid. Chemoterapia 1987; 6: 437-439.
13. Davies S, Sparham P D, Spencer R C. Comparative in-vitro activity of five fluoroquinolones against mycobacteria. J Antimicrob Chemother 1987; 19: 605-609.
14. Berlin O G, Young L S, Bruckner D A. In vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis. J Antimicrob Chemother 1987; 19: 611-615.
15. Yew W W, Piddock L J V, Li M S K, Lyon D, Chan C Y, Cheng A F B. In vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother 1994; 34: 770-774.
16. Fenlon C H, Cynamon M H. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. Antimicrob Agents Chemother 1986; 29: 386-388.
17. Pfyffer G E, Bonato D A, Ebrahimzadeh A, et al. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid medium. J Clin Microbiol 1999; 37: 3179-3186.
18. Kaplan J A, Krieff D M. Quinolones for the treatment and prophylaxis of tuberculosis. Ann Pharmacother 1996; 30: 1020-1022.